PRO120 EVOLUTION OF OBCS NECESSARY TO ACTIVATE VALUE WITHIN STEM CELL & GENE THERAPIES & RARE DISEASES
N. Eslami
◽
S. Garfield
◽
S. Richardson
◽
N. Negi
Karen E Pollok
◽
Shanbao Cai
2004 ◽
Vol 4
(3)
◽
pp. 263-276
◽
Peter Haviernik
◽
Kevin Bunting
2003 ◽
Vol 3
(5)
◽
pp. 387-394
◽
T. Yokoo
◽
K. Sakurai
◽
T. Ohashi
◽
T. Kawamura
2012 ◽
Vol 39
(9)
◽
pp. 8717-8722
◽
Chen Liu
◽
Hongpeng Xue
◽
Yixia Lu
◽
Baorong Chi
2021 ◽
Vol 132
(2)
◽
pp. S107
Niek P. van Til
◽
Yildirim Dogan
◽
Cecilia Barese
◽
Zeenath Unnisa
◽
Swaroopa Guda
◽
...
2019 ◽
Vol 178
(2)
◽
pp. 251-261
Zhe-Bin Liu
◽
Nader E. Ezzedine
◽
Agda K. Eterovic
◽
Joe E. Ensor
◽
Helen J. Huang
◽
...
2020 ◽
Vol 14
(5)
◽
pp. 974-990
◽
Neha Singh
◽
Sathish K. R. Padi
◽
Jeremiah J. Bearss
◽
Ritu Pandey
◽
Koichi Okumura
◽
...
F. Fumagalli
◽
V. Calbi
◽
A. Zambon
◽
F. Ciotti
◽
L. Lorioli
◽
...
2014 ◽
Vol 22
◽
pp. S106
◽